Rituximab experience in a resistant thrombotic thrombocytopenic purpura case

A. Beste Öztepe
2017 Istanbul Bilim University Florence Nightingale Journal of Medicine  
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening condition characterized with microangiopathic hemolytic anemia, thrombocytopenia, fever, neurological findings, and renal failure. The standard treatment of TTP is plasma exchange and corticosteroids; however, many patients require additional immunosuppression. In this article, we present a refractory TTP case that did not respond to a treatment of daily two doses of plasma exchange and corticosteroid, and that recovered rapidly
more » ... ecovered rapidly with rituximab treatment.
doi:10.5606/fng.btd.2017.014 fatcat:oeunqdrivzdhbjx4qmbiqmtivq